{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T13:20:04Z","timestamp":1777900804427,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1016\/j.bcp.2004.12.010","type":"journal-article","created":{"date-parts":[[2005,2,11]],"date-time":"2005-02-11T04:35:31Z","timestamp":1108096531000},"page":"951-960","source":"Crossref","is-referenced-by-count":40,"title":["Activity profiles of deoxynucleoside kinases and 5\u2032-nucleotidases in cultured adipocytes and myoblastic cells: insights into mitochondrial toxicity of nucleoside analogs"],"prefix":"10.1016","volume":"69","author":[{"given":"Svetlana N.","family":"Rylova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Freidoun","family":"Albertioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunnar","family":"Flygh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Staffan","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2004.12.010_bib1","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S0140-6736(00)02854-3","article-title":"Adverse effects of antiretroviral therapy","volume":"356","author":"Carr","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2004.12.010_bib2","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0149-2918(00)80064-8","article-title":"Clinical manifestations and management of antiretroviral nucleoside analog-related mitochondrial toxicity","volume":"22","author":"Moyle","year":"2000","journal-title":"Clin Therapeut"},{"key":"10.1016\/j.bcp.2004.12.010_bib3","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/S0140-6736(99)06102-4","article-title":"Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy","volume":"354","author":"Brinkman","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2004.12.010_bib4","first-page":"140","article-title":"Update on mitochondrial toxicity of antiretrovirals and its link to lipodystrophy","volume":"4","author":"McComsey","year":"2002","journal-title":"AIDS Rev"},{"key":"10.1016\/j.bcp.2004.12.010_bib5","first-page":"140","article-title":"Mitochondrial toxicity of nucleoside analogue reverse transcriptase inhibitors: lactic acidosis, risk factors and therapeutic options","volume":"1","author":"Brinkman","year":"1999","journal-title":"AIDS Rev"},{"key":"10.1016\/j.bcp.2004.12.010_bib6","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/nrd1201","article-title":"Mitochondrial toxicity of NRTI antiviral drugs: an integrated cellular perspectives","volume":"2","author":"Lewis","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bcp.2004.12.010_bib7","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/0140-6736(91)91294-5","article-title":"Depletion of musle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy","volume":"337","author":"Arnaudo","year":"1991","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.bcp.2004.12.010_bib8","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1097\/00002030-200306130-00007","article-title":"Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy","volume":"17","author":"Nolan","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.bcp.2004.12.010_bib9","first-page":"743","article-title":"The cellular pharmacology of nucleoside- and nucleotide-analogue reverse-transcriptase inhibitors and its relationship to clinical toxicities","volume":"38","author":"Anderson","year":"2004","journal-title":"HIV\/AIDS CID"},{"key":"10.1016\/j.bcp.2004.12.010_bib10","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0168-8278(99)80020-8","article-title":"Zidovudine-induced mitochondrial disorder with massive liver steatosis, myopathy, lactic acidosis, and mitochondrial DNA depletion","volume":"30","author":"Chariot","year":"1999","journal-title":"J Hepatol"},{"issue":"50","key":"10.1016\/j.bcp.2004.12.010_bib11","doi-asserted-by":"crossref","first-page":"14711","DOI":"10.1021\/bi035596s","article-title":"Toxicity of nucleoside analogues used to treat AIDS and the selectivity of the mitochondrial DNA polymerase","volume":"42","author":"Le","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcp.2004.12.010_bib12","doi-asserted-by":"crossref","first-page":"23616","DOI":"10.1074\/jbc.M101114200","article-title":"Differential incorporation and removal of antiviral deoxynucleotides by human DNA polymerase \u03b3","volume":"276","author":"Lim","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2004.12.010_bib13","doi-asserted-by":"crossref","first-page":"23832","DOI":"10.1074\/jbc.M101156200","article-title":"Insights into the molecular mechanism of mitochondrial toxicity by AIDS drugs","volume":"276","author":"Feng","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2004.12.010_bib14","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1128\/AAC.46.3.716-723.2002","article-title":"Assessment of mitochondrial toxicity in human cells treated with tenofovir: comparison with other nucleoside reverse transcriptase inhibitors","volume":"46","author":"Birkus","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bcp.2004.12.010_bib15","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0163-7258(95)00015-9","article-title":"Mammalian deoxyribonucleoside kinases","volume":"67","author":"Arner","year":"1995","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.bcp.2004.12.010_bib16","doi-asserted-by":"crossref","first-page":"46195","DOI":"10.1074\/jbc.R300032200","article-title":"Mammalian 5\u2032-nucleotidases","volume":"278","author":"Bianchi","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2004.12.010_bib17","doi-asserted-by":"crossref","first-page":"8239","DOI":"10.1073\/pnas.97.15.8239","article-title":"A deoxyribonucleotidas in mitochondria: involvement in regulation of dNTP pools and possible link to genetic disease","volume":"S 97","author":"Rampazzo","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2004.12.010_bib18","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1073\/pnas.031430998","article-title":"The human mitochondrial deoxynucleotide carrier and its role in the toxicity of nucleoside antivirals","volume":"98","author":"Dolce","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2004.12.010_bib19","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1007\/BF00878661","article-title":"Mitochondrial DNA levels in the brain of HIV-positive patients after zidovudine therapy","volume":"243","author":"Davison","year":"1996","journal-title":"J Neurol"},{"key":"10.1016\/j.bcp.2004.12.010_bib20","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/ng751","article-title":"Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy","volume":"29","author":"Saada","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.bcp.2004.12.010_bib21","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/ng746","article-title":"The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA","volume":"29","author":"Mandel","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.bcp.2004.12.010_bib22","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1093\/hmg\/ddg192","article-title":"Mitochondrial DNA depletion can be prevented by dGMP and dAMP supplemetation in a resting culture of deoxyguanosine kinase-deficient fibroblasts","volume":"12","author":"Taanman","year":"2003","journal-title":"Hum Mol Gen"},{"key":"10.1016\/j.bcp.2004.12.010_bib23","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1016\/S0021-9258(18)89409-1","article-title":"Evidence for the involvement of vicinal sulfhydryl groups in insulin-activated hexose transport by 3T3-L1 adipocytes","volume":"260","author":"Frost","year":"1985","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2004.12.010_bib24","doi-asserted-by":"crossref","first-page":"E925","DOI":"10.1152\/ajpendo.1998.275.6.E925","article-title":"Regulation of glycogen accumulation in L6 myotubes cultured under optimized differentiation condition","volume":"275","author":"Elsner","year":"1998","journal-title":"Am Physiol Endocrinol Metab"},{"key":"10.1016\/j.bcp.2004.12.010_bib25","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0014-4827(84)90774-2","article-title":"Deoxyribonucleoside triphosphate metabolism and the mammalian cell cycle. Effects of thymidine on wild-type and dCMP deaminase-deficient mouse S49 T-lymphoma cells","volume":"155","author":"Eriksson","year":"1984","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.bcp.2004.12.010_bib26","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0076-6879(78)51045-8","article-title":"Deoxycytidine kinase from calf thymus","volume":"51","author":"Ives","year":"1978","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.bcp.2004.12.010_bib27","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/0006-291X(92)91114-6","article-title":"Selective assays for thymidine kinase 1 and 2 and deoxycytidine kinase and their activities in extracts from human cells and tissues","volume":"188","author":"Arner","year":"1992","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bcp.2004.12.010_bib28","doi-asserted-by":"crossref","first-page":"22847","DOI":"10.1016\/S0021-9258(18)41605-5","article-title":"Substrate specificity of mitochondrial 2\u2032-deoxyguanosine kinase","volume":"268","author":"Wang","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2004.12.010_bib29","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1006\/abbi.1996.0537","article-title":"Cloning and expression of cDNA encoding uridine kinase from mouse brain","volume":"336","author":"Ropp","year":"1996","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.bcp.2004.12.010_bib30","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0006-2952(98)00032-X","article-title":"Decrease in thymidilate kinase activity in peripheral blood mononuclear cells from HIV-infected individuals","volume":"56","author":"Jacobsson","year":"1998","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2004.12.010_bib31","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0006-291X(02)00206-1","article-title":"5\u2032-Nucleotidases: specific assays for five different enzymes in cell extracts","volume":"293","author":"Rampazzo","year":"2002","journal-title":"Biochem Biophys Res Comun"},{"key":"10.1016\/j.bcp.2004.12.010_bib32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0076-6879(69)13005-0","article-title":"Citrate synthase","volume":"13","author":"Srere","year":"1969","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.bcp.2004.12.010_bib33","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1091\/mbc.E02-03-0156","article-title":"IGF-I-induced differentiation of L6 myogenic cells requires the activity of cAMP-phosphodiesterase","volume":"14","author":"De Arcangelis","year":"2003","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.bcp.2004.12.010_bib34","series-title":"Recent advances in nucleoside: chemistry and chemotherapy","first-page":"455","article-title":"The role of the cellular deoxynucleoside kinases in activation of nucleoside analogs used in chemotherapy","author":"Eriksson","year":"2002"},{"key":"10.1016\/j.bcp.2004.12.010_bib35","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0006-2952(03)00290-9","article-title":"Cytosolic and mitochondrial deoxynucleotidases: activity with substrate analogs, inhibitors and implications for therapy","volume":"66","author":"Mazzon","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2004.12.010_bib36","doi-asserted-by":"crossref","first-page":"9032","DOI":"10.1016\/S0021-9258(18)31547-3","article-title":"Diverging substrate specificity of pure human thymidine kinases 1 and 2 against antiviral dideoxynucleosides","volume":"266","author":"Munch-Petersen","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2004.12.010_bib37","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.bbrc.2003.09.104","article-title":"Mitochondrial deoxyribonucleoside triphosphate pools in thymidine kinase 2 deficiency","volume":"310","author":"Saada","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bcp.2004.12.010_bib38","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0014-5793(03)01181-5","article-title":"Mitochondrial deoxyguanosine kinase mutations and mitochondrial DNA depletion syndrome","volume":"554","author":"Wang","year":"2003","journal-title":"FEBS"},{"key":"10.1016\/j.bcp.2004.12.010_bib39","doi-asserted-by":"crossref","first-page":"6963","DOI":"10.1074\/jbc.M206143200","article-title":"Kinetic properties of mutant human thymidine kinase 2 suggests a mechanism for mitochondrial DNA depletion myopathy","volume":"278","author":"Wang","year":"2003","journal-title":"J Biol Chem"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295205000080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295205000080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T01:36:31Z","timestamp":1625448991000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295205000080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["S0006295205000080"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2004.12.010","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2005,3]]}}}